GUYMARK UK LIMITEDActive

Company number 03934847Private limited companyIncorporated 2000

Key figures

£2,455,693+28.7%
Net assets 2025
+38.0%
Average annual growth 2022–2025
01 m2 m3 m2022202320242025

GUYMARK UK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m6 m2022202320242025
Filed accounts2022–2025
2022202320242025
Turnover3,813,8874,515,387——
Profit for the year351,473375,532597,737547,388
Cash at bank and in hand464,249609,9231,520,9001,660,378
Total assets1,401,8791,745,0182,548,3084,180,093
Total liabilities674,556669,865935,1651,966,755
Net assets / total equity935,0361,310,5681,908,3052,455,693
Average number of employees2323250

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GUYMARK UK LIMITED

Company

GUYMARK UK LIMITED is a private limited company registered with Companies House under company number 03934847. It was incorporated on 28 Feb 2000. Its status is active. The registered office is in Birmingham (B37). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Profit for the year was £547,388. Net assets were £2,455,693, up 28.7% on the previous year. Cash at bank and in hand was £1,660,378. Total assets were £4,180,093 and total liabilities £1,966,755. The company had an average of 0 employees. Figures are available for 4 financial years (2022–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 6 Feb 2027.